1.
Hanna L, O’Dwyer R, Hamilou Z, Noonan K, Doucette S, Sridhar SS. Expert opinion on the management of anemia in prostate cancer patients receiving PARP inhibitors. CUAJ [Internet]. 2025 Dec. 1 [cited 2026 Apr. 30];19(12):422-31. Available from: https://cuaj.ca/index.php/journal/article/view/9401